DE2760284C2 - - Google Patents

Info

Publication number
DE2760284C2
DE2760284C2 DE2760284A DE2760284A DE2760284C2 DE 2760284 C2 DE2760284 C2 DE 2760284C2 DE 2760284 A DE2760284 A DE 2760284A DE 2760284 A DE2760284 A DE 2760284A DE 2760284 C2 DE2760284 C2 DE 2760284C2
Authority
DE
Germany
Prior art keywords
salicylate
choline salicylate
mixture
composition according
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2760284A
Other languages
German (de)
English (en)
Inventor
Ernest J. Yonkers N.Y. Us Sasmor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mundipharma AG
Original Assignee
Mundipharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/705,056 external-priority patent/US4067974A/en
Application filed by Mundipharma AG filed Critical Mundipharma AG
Application granted granted Critical
Publication of DE2760284C2 publication Critical patent/DE2760284C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE2760284A 1976-01-21 1977-01-15 Expired - Lifetime DE2760284C2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65111076A 1976-01-21 1976-01-21
US05/705,056 US4067974A (en) 1976-01-21 1976-07-14 Stabilized solid form choline salicylate compositions

Publications (1)

Publication Number Publication Date
DE2760284C2 true DE2760284C2 (es) 1990-08-02

Family

ID=27096002

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2760284A Expired - Lifetime DE2760284C2 (es) 1976-01-21 1977-01-15
DE19772701553 Granted DE2701553A1 (de) 1976-01-21 1977-01-15 Stabilisierte feste cholin-salicylat- mischungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19772701553 Granted DE2701553A1 (de) 1976-01-21 1977-01-15 Stabilisierte feste cholin-salicylat- mischungen

Country Status (23)

Country Link
JP (1) JPS6051449B2 (es)
AR (1) AR217249A1 (es)
AU (1) AU511510B2 (es)
CA (1) CA1070299A (es)
CH (1) CH635816A5 (es)
DD (1) DD128908A5 (es)
DE (2) DE2760284C2 (es)
DK (1) DK149804C (es)
EG (1) EG12511A (es)
ES (1) ES454712A1 (es)
FI (1) FI56770C (es)
FR (1) FR2338705A1 (es)
GB (2) GB1575977A (es)
GR (1) GR62110B (es)
HU (1) HU175973B (es)
IL (1) IL50992A (es)
MX (1) MX5920E (es)
NL (1) NL183821C (es)
NO (1) NO145295C (es)
NZ (1) NZ182810A (es)
RO (1) RO71764A (es)
SE (1) SE418799B (es)
YU (1) YU40159B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043168A (en) * 1990-04-26 1991-08-27 Sidmak Laboratories, Inc. Solid choline magnesium salicylate composition and method of preparing same
US5217965A (en) * 1991-06-17 1993-06-08 Euroceltique, S.A. Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759980A (en) * 1969-05-26 1973-09-18 Stockton Chemicals Inc Salicylates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3347744A (en) * 1963-10-25 1967-10-17 Smith Kline French Lab Magnesium hydroxide suspensions
US3297529A (en) * 1964-11-25 1967-01-10 Sutton Lab Inc Magnesium sulfate stabilized choline salicylate
US3326760A (en) * 1966-05-17 1967-06-20 Synergistics Inc Choline salicylate polygalacturonate therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759980A (en) * 1969-05-26 1973-09-18 Stockton Chemicals Inc Salicylates

Also Published As

Publication number Publication date
SE7614538L (sv) 1977-07-22
NO145295B (no) 1981-11-16
EG12511A (en) 1979-06-30
RO71764A (ro) 1980-10-30
FI56770B (fi) 1979-12-31
NO770172L (no) 1977-07-22
ES454712A1 (es) 1977-12-01
NL7700514A (nl) 1977-07-25
NZ182810A (en) 1979-12-11
DK149804C (da) 1987-03-09
NL183821C (nl) 1989-02-01
DE2701553C2 (es) 1987-11-12
FR2338705B1 (es) 1980-04-04
AU511510B2 (en) 1980-08-21
IL50992A (en) 1980-06-30
GR62110B (en) 1979-02-26
YU40159B (en) 1985-08-31
AU2141977A (en) 1978-07-27
GB1575977A (en) 1980-10-01
CH635816A5 (en) 1983-04-29
DK21677A (da) 1977-07-22
JPS5294414A (en) 1977-08-09
DE2701553A1 (de) 1977-07-28
NL183821B (nl) 1988-09-01
NO145295C (no) 1982-02-24
FR2338705A1 (fr) 1977-08-19
HU175973B (en) 1980-11-28
DK149804B (da) 1986-10-06
MX5920E (es) 1984-08-28
FI763741A (es) 1977-07-22
YU6977A (en) 1982-10-31
FI56770C (fi) 1980-04-10
DD128908A5 (de) 1977-12-14
SE418799B (sv) 1981-06-29
AR217249A1 (es) 1980-03-14
IL50992A0 (en) 1977-01-31
GB1575978A (en) 1980-10-01
CA1070299A (en) 1980-01-22
JPS6051449B2 (ja) 1985-11-14

Similar Documents

Publication Publication Date Title
DE2224534C3 (de) Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe
DE2813480C2 (de) Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DD216163A5 (de) Verfahren zur herstellung eines oral verabfolgbaren cefaclor-praeparates mit verzoegerter wirkstoffabgabe
EP0435913B1 (de) Brausetablette
DE69022678T2 (de) S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
EP0009688A2 (de) Medikiertes Tierfutter auf Basis Lebermehl und Verfahren zu seiner Herstellung
EP2068842B1 (de) Wirkstoff und trimagnesiumdicitrat als trockenmittel enthaltende stabilisierte feste arzneimittelformen und verfahren zu ihrer herstellung
DD144719A5 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
AT500521B1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend antibiotisches fosfomycin-tromethamol
EP0146863A2 (de) Orale retardierte Acetylsalicylsäureformulierungen
DE2760284C2 (es)
DE1935879A1 (de) Pharmazeutisches Praeparat und Verfahren zur Herstellung von diesem
DE2519528C2 (es)
DE69100954T2 (de) Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung.
DE68907268T2 (de) Verwendung von Phytinsäure als Antidot gegen Alkoholvergiftung.
EP0641200B1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
DE19726871C1 (de) Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe
CH640416A5 (de) Oral verabreichbare, stabile, feste pharmazeutische zusammensetzung in kapseldosierungseinheitsform zur bekaempfung von angstzustaenden.
DE69103724T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
CH647678A5 (en) Solid composition with improved choline salicylate stability
DE2826642C2 (de) Orales Urolithiasismittel
DE69000268T2 (de) Stabilisiertes antitumormittel.

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2701553

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 2701553

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 2701553

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition